Business Standard

GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD

Shingrix is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above, says GSK Pharmaceuticals MD Bhushan Akshikar

Bhushan Akshikar
Premium

Bhushan Akshikar, MD, GSK Pharmaceuticals

Sohini Das Mumbai

Listen to This Article

GlaxoSmithKline Pharmaceuticals, launched the Herpes Zoster vaccine named Shingrix on Monday, is now focusing on adult vaccination in the country. GSK Pharmaceuticals MD Bhushan Akshikar talks to Sohini Das about the company’s India plans. Edited excerpts:

Why is it important to take the Shingles (Herpes Zoster) vaccine for adults?

Shingrix (Zoster vaccine recombinant) is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above. It’s the world’s first non-live recombinant subunit vaccine administered through the intramuscular route in two doses.

Shingles is caused by re-activation of the

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 24 2023 | 7:37 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com